 Frazier Healthcare Partners announced today the closing of Frazier Life Sciences X, L.P., exceeding its target and closing on more than 617 million in capital commitments in an oversubscribed fundraise. Investing in life sciences has been a core strategy since the firms inception 29 years ago, and Frazier Life Sciences X marks the third dedicated Life Sciences fund, bringing the firms total committed capital raised since inception to nearly 4.8 billion. 